Quinolone antibiotic

0 marketed 1 in Phase 3 1 in Phase 2

This page covers all Quinolone antibiotic drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting DNA gyrase and topoisomerase IV.

Targets

DNA gyrase and topoisomerase IV

Phase 3 pipeline (1)

ozenoxacin 1% cream · Ferrer Internacional S.A. · Dermatology
Ozenoxacin is a quinolone antibiotic that inhibits bacterial DNA gyrase and topoisomerase IV.

Phase 2 pipeline (1)

Gatifloxacin 0.3% ophthalmic solution · Allergan · Infectious Disease
Quinolone antibiotic that inhibits bacterial DNA gyrase and topoisomerase IV.